Item 8.01. Other Events.

On January 10, 2022, Iovance Biotherapeutics, Inc. (the "Company") issued a press release. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.






(d)    Exhibits.



Exhibit No.                                Description
   99.1         Press Release of Iovance Biotherapeutics, Inc., dated January 10,
              2022.
    104       Cover Page Interactive Data File (formatted as Inline XBRL and
              contained in Exhibit 101)

© Edgar Online, source Glimpses